S Heimfeld
- Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation 23
- Chronic Myeloid Leukemia Treatments 4
- Genetics top 2%
- Virus-based gene therapy research 9
- Mesenchymal stem cell research 6
- Chronic Lymphocytic Leukemia Research 4
- Immunology top 5%
- Immune Cell Function and Interaction 6
- Transplantation top 10%
- Oncology top 10%
- Cancer Cells and Metastasis 5
- Neutropenia and Cancer Infections 4
- Co-authors
- Irving L. WeissmanLawrence SmithGerald J. SpangrudeMatt van de RijnZhiquan ShuDayong GaoRJ BerensonLothar Kanz
- Cited by
- HematologyGeneticsImmunology
- Journals
- Bone Marrow Transplantation (9 papers)Blood (6 papers)The Journal of Experimental Medicine (3 papers)
- Partner nations
- United StatesSouth AfricaSwitzerland
In The Last Decade
S Heimfeld
43 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 99
- Hematology 1.2k
- Genetics 470
- Immunology 698
- Transplantation 44
- Oncology 436
Countries citing papers authored by S Heimfeld
This map shows the geographic impact of S Heimfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Heimfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Heimfeld more than expected).
Fields of papers citing papers by S Heimfeld
This network shows the impact of papers produced by S Heimfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Heimfeld. The network helps show where S Heimfeld may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S Heimfeld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 8 | |
| 2 | 2013 | 155 | |
| 3 | 2009 | 10 | |
| 4 | 2005 | 7 | |
| 5 | 2003 | 39 | |
| 6 | 2003 | 45 | |
| 7 | 2001 | 19 | |
| 8 | 2000 | 42 | |
| 9 | 1996 | 19 | |
| 10 | The human multiple drug resistance gene (mdr-1) is used to confer chemoprotection upon hematopoietic progenitor cells in a clinical gene therapy trial setting for ovarian and breast cancer treatment | 1996 | 1 |
| 11 | 1995 | 49 | |
| 12 | Hematopoietic stem cell transplantation | 1995 | 1 |
| 13 | Hematopoietic stem cells transplantation | 1994 | 3 |
| 14 | 1994 | 96 | |
| 15 | Transplantation of CD34+ marrow and/or PBPCS into breast cancer patients following high-dose chemotherapy | 1994 | 1 |
| 16 | 1993 | 10 | |
| 17 | 1992 | 20 | |
| 18 | 1991 | 30 | |
| 19 | 1989 | 9 | |
| 20 | 1988 | 81 |
About S Heimfeld
S Heimfeld is a scholar working on Hematology, Genetics, Oncology, Immunology and Transplantation, having authored 43 papers that have together received 2.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (23 papers), Virus-based gene therapy research (9 papers), Mesenchymal stem cell research (6 papers), Immune Cell Function and Interaction (6 papers), Cancer Cells and Metastasis (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Neutropenia and Cancer Infections (4 papers). The work is most often cited by research in Hematology (1.2k citations), Genetics (470 citations), Immunology (698 citations), Transplantation (44 citations) and Oncology (436 citations). S Heimfeld has collaborated with scholars based in United States, South Africa and Switzerland. Frequent co-authors include Irving L. Weissman, Lawrence Smith, Gerald J. Spangrude, Matt van de Rijn, Zhiquan Shu, Dayong Gao, RJ Berenson, Lothar Kanz, W. Brugger and R Mertelsmann. Their work appears in journals such as Bone Marrow Transplantation, Blood, The Journal of Experimental Medicine, Proceedings of the National Academy of Sciences and Stem Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.